Use of new Boston Scientific device should be limited, one expert says

CHICAGO (Reuters) - Boston Scientific Corp's new leadless implantable heart defibrillator, hailed by some as a breakthrough, should be used on a limited basis until more data are collected, a prominent cardiologist wrote in an editorial of a top medical journal.
Source: Modern Medicine - Category: Journals (General) Source Type: news